Endocrinology and Diabetes In the Department of Pediatrics
   Patient List Research Consent Form

Patient List Research Consent Form

The Division of Pediatric Endocrinology and Diabetes at Stanford is actively involved in clinical research. The department has several on-going studies, as well as ones that are open for enrollment. If you are interested in being contacted about future studies, please sign the Patient List Research Consent Form. Once completed, please return it at your next clinic appointment or by mail to the following:

Bonita Baker
Division of Pediatric Endocrinology and Diabetes
Stanford University School of Medicine
Room G-313 Medical Center
300 Pasteur Drive
Stanford, CA, USA 94305-5208

Subject Recruitment

The following studies are currently recruiting study subjects. Please click on the study title for more information.

Study Title

Looking for...

Type 1 Diabetes TrialNet: Pathway to Prevention

Relatives of people with type 1 diabetes. First degree blood relatives ages 1-45 and second degree relatives ages 1-20.

If you wish to do remote screening through Quest

www.pathway2prevention.org/?5

Type 1 Diabetes TrialNet: Oral Insulin Study

 

Relatives of people with type 1 diabetes. Start with the Pathway to Prevention Study

TrialNet Type 1 Diabetes Protocol TN-18, CTLA-4 Ig (Abatacept) for Prevention of Abnormal Glucose Tolerance and Diabetes in Relatives At-Risk for Type 1 Diabetes Mellitus

Relatives of people with type 1 diabetes. Start with the Pathway to Prevention Study
Type I Diabetes TrialNet Protocol TN-10, Anti-CD3 mAb (Teplizumab) for Prevention of Diabetes in Relatives At-Risk for
Type 1 Diabetes Mellitus
Relatives of people with type 1 diabetes. Start with the Pathway to Prevention Study
The T1D Exchange Type 1 Diabetes Network Individuals with type 1 diabetes.

 

 

Below are studies we generally offer to potential subjects during a clinical visit  
Shared Medical Visits Consent Assent Handout
TN LIFT (longterm followup) Consent Assent Handbook
Nocturnal Hypoglycemia Prevention Consent
Agenesis Project Consent Assent
DKA Brain Compliance Device Consent Assent
DKA Neurocognition Consent Assent Handout
Diabetes Antibody Assay Development Consent Assent Short Form
Diabetes Etiology Sample Consent Assent Short Form
Glucagon Control Consent
Aromatase Inhibitor Growth Study Growth study for pubertal MALES older than 10 years.
Development of Algorithms for a Prototype Closed Loop Insulin Pump (Closed Loop 1) Patients with type 1 diabetes ages 3-31 who were diagnosed within the past year and are currently using an insulin pump.
Sponsored multicenter depot lupron study  
Depot Lupron Study Patients with newly diagnosed Central Precocious Puberty who have not
started medical therapy.
Comparison of transdermal and oral estrogens in adolescents with
ovarian failure
Consent Assent
General Use of a Glucose Sensor Consent Assent
Growth Hormone Therapy Patients and families who are interested in growth hormone therapy should be evaluated by a pediatric endocrinologist to determine appropriateness of treatment.  Risks and
benefits of growth hormone therapy are reveiwed in the consent form.
Pediatric Intensive Care Unit Project Patients hospitalized in the pediatric intensive care unit with hyperglycemia within the past 12 hours.
CLINICAL Pamidronate Therapy for Children Consent

Diabetes Consortium consent assent

Data collection protocol
 

 

Shared Studies consent assent

This is an IRB approved protocol to allow Stanford to do some tests required of OUTSIDE protocols here at Stanford when appropriate.

Please check back for study updates and the addition of new studies.

Stanford Medicine Resources:

Footer Links: